Role of imaging in the diagnosis, staging, and treatment of thymoma

Radiographics

Volumn 31, Issue 7, 2011, Pages 1847-1861

  Benveniste, Marcelo F K ^a   Rosado de Christenson, Melissa L ^b,c   Sabloff, Bradley S ^a   Moran, Cesar A ^a   Swisher, Stephen G ^a   Marom, Edith M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ST LUKE S HOSPITAL   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER STAGING; DIAGNOSTIC IMAGING; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; PATHOLOGY; PROGNOSIS; THYMOMA;

DIAGNOSTIC IMAGING; HUMANS; IMAGE ENHANCEMENT; NEOPLASM STAGING; PROGNOSIS; THYMOMA; THYMUS NEOPLASMS;

EID: 81255184715     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.317115505     Document Type: Article

References (52)

1. Morgenthaler TI, Brown LR, Colby TV, Harper CM, Coles DT. Thymoma. Mayo Clin Proc 1993;68 (11):1110-1123.
2. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, eds. Pathology & genetics: tumours of the lung, pleura, thymus and heart. World Health Organization classifcation of tumours, vol 10. Lyon, France: IARC, 2004.
3. Rosado-de-Christenson ML, Strollo DC, Marom EM. Imaging of thymic epithelial neoplasms. Hema-tol Oncol Clin North Am 2008;22(3):409-431.
4. Regnard JF, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardio-vasc Surg 1996;112(2):376-384.
5. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma: a clinicopathologic review. Cancer 1987;60(11):2727-2743.
6. Osserman KE, Genkins G. Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 1971;38(6):497-537.
7. Cameron RB, Loehrer PJS, Thomas CRJ. Neoplasms of the mediastinum. In: DeVita VTJ, Hell-man S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia, Pa: Lippincott Williams & Wilkins, 2005; 845-858.
8. Levy Y, Afek A, Sherer Y, et al. Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature. Semin Arthritis Rheum 1998;28(2):73-79.
9. Rieker RJ, Hoegel J, Morresi-Hauf A, et al. His-tologic classifcation of thymic epithelial tumors: comparison of established classifcation schemes. Int J Cancer 2002;98(6):900-906.
10. Suster S, Moran CA. Histologic classifcation of thymoma: the World Health Organization and beyond. Hematol Oncol Clin North Am 2008;22(3): 381-392.
11. Detterbeck FC. Clinical value of the WHO classif-cation system of thymoma. Ann Thorac Surg 2006; 81(6):2328-2334.
12. Gamondès JP, Balawi A, Greenland T, et al. Seventeen years of surgical treatment of thymoma: factors infuencing survival. Eur J Cardiothorac Surg 1991; 5(3):124-131.
13. Koga K, Matsuno Y, Noguchi M, et al. A review of 79 thymomas: modifcation of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44(5): 359-367.
14. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48(11): 2485-2492.
15. Yamakawa Y, Masaoka A, Hashimoto T, et al. A tentative tumor-node-metastasis classifcation of thymoma. Cancer 1991;68(9):1984-1987.
16. Huang J, Detterbeck FC, Wang Z, Loehrer PJ. Standard outcome measures for thymic malignancies. J Thorac Oncol 2010;5(12):2017-2023.
17. Falkson CB, Bezjak A, Darling G, et al. The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 2009;4(7):911-919.
18. Girard N, Mornex F, Van Houtte P, Cordier JF, van Schil P. Thymoma: a focus on current therapeutic management. J Thorac Oncol 2009;4(1):119-126.
19. Detterbeck FC, Moran C, Huang J, et al. Which way is up? policies and procedures for surgeons and pathologists of resection specimens of thymic malignancy. J Thorac Oncol 2011;6(7 suppl 3):S1730-S1738.
20. Blumberg D, Port JL, Weksler B, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg 1995;60(4):908-913; discussion 914.
21. Nakagawa K, Asamura H, Matsuno Y, et al. Thy-moma: a clinicopathologic study based on the new World Health Organization classifcation. J Thorac Cardiovasc Surg 2003;126(4):1134-1140.
22. Wright CD, Wain JC, Wong DR, et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg 2005;130(5):1413-1421.
23. Casey EM, Kiel PJ, Loehrer PJ Sr. Clinical management of thymoma patients. Hematol Oncol Clin North Am 2008;22(3):457-473.
24. Kim ES, Putnam JB, Komaki R, et al. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: fnal report. Lung Cancer 2004;44(3):369-379.
25. Elkiran ET, Abali H, Aksoy S, et al. Thymic epithelial neoplasia: a study of 58 cases. Med Oncol 2007; 24(2):197-201.
26. Rea F, Sartori F, Loy M, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardio-vasc Surg 1993;106(3):543-549.
27. Venuta F, Rendina EA, Longo F, et al. Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76(6):1866-1872; discussion 1872.
28. Venuta F, Rendina EA, Pescarmona EO, et al. Mul-timodality treatment of thymoma: a prospective study. Ann Thorac Surg 1997;64(6):1585-1591; discussion 1591-1592.
29. Regnard JF, Zinzindohoue F, Magdeleinat P, Guibert L, Spaggiari L, Levasseur P. Results of re-resection for recurrent thymomas. Ann Thorac Surg 1997;64(6):1593-1598.
30. Ströbel P, Bauer A, Puppe B, et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 2004;22(8):1501-1509.
31. Marom EM. Imaging thymoma. J Thorac Oncol 2010;5(10 suppl 4):S296-S303.
32. Nicolaou S, Müller NL, Li DK, Oger JJ. Thymus in myasthenia gravis: comparison of CT and pathologic findings and clinical outcome after thymec-tomy. Radiology 1996;201(2):471-474.
33. Inaoka T, Takahashi K, Mineta M, et al. Thymic hy-perplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 2007; 243(3):869-876.
34. Takahashi K, Inaoka T, Murakami N, et al. Characterization of the normal and hyperplastic thymus on chemical-shift MR imaging. AJR Am J Roentgenol 2003;180(5):1265-1269.
35. Moran CA, Travis WD, Rosado-de-Christenson M, Koss MN, Rosai J. Thymomas presenting as pleu-ral tumors: report of eight cases. Am J Surg Pathol 1992;16(2):138-144.
36. Brown LR, Muhm JR, Gray JE. Radiographic detection of thymoma. AJR Am J Roentgenol 1980;134 (6):1181-1188.
37. Jeong YJ, Lee KS, Kim J, Shim YM, Han J, Kwon OJ. Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR Am J Roentgenol 2004;183(2):283-289.
38. Chen JL, Weisbrod GL, Herman SJ. Computed tomography and pathologic correlations of thymic lesions. J Thorac Imaging 1988;3(1):61-65.
39. Fon GT, Bein ME, Mancuso AA, Keesey JC, Lu-petin AR, Wong WS. Computed tomography of the anterior mediastinum in myasthenia gravis: a radio-logic-pathologic correlative study. Radiology 1982; 142(1):135-141.
40. Tomiyama N, Johkoh T, Mihara N, et al. Using the World Health Organization classifcation of thymic epithelial neoplasms to describe CT findings. AJR Am J Roentgenol 2002;179(4):881-886.
41. Sadohara J, Fujimoto K, Müller NL, et al. Thymic epithelial tumors: comparison of CT and MR imaging findings of low-risk thymomas, high-risk thy-momas, and thymic carcinomas. Eur J Radiol 2006; 60(1):70-79.
42. Yakushiji S, Tateishi U, Nagai S, et al. Computed to-mographic findings and prognosis in thymic epithelial tumor patients. J Comput Assist Tomogr 2008; 32(5):799-805.
43. Tomiyama N, Müller NL, Ellis SJ, et al. Invasive and noninvasive thymoma: distinctive CT features. J Comput Assist Tomogr 2001;25(3):388-393.
44. Priola AM, Priola SM, Di Franco M, Cataldi A, Durando S, Fava C. Computed tomography and thymoma: distinctive findings in invasive and non-invasive thymoma and predictive features of recurrence. Radiol Med (Torino) 2010;115(1):1-21.
45. Marom EM, Milito MA, Moran CA, et al. Computed tomography findings predicting invasiveness of thymoma. J Thorac Oncol 2011;6(7):1274-1281.
46. Maher MM, Shepard JA. Imaging of thymoma. Se-min Thorac Cardiovasc Surg 2005;17(1):12-19.
47. Restrepo CS, Pandit M, Rojas IC, et al. Imaging findings of expansile lesions of the thymus. Curr Probl Diagn Radiol 2005;34(1):22-34.
48. Sakai S, Murayama S, Soeda H, Matsuo Y, Ono M, Masuda K. Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol 2002;43(3):262-268.
49. Loehrer PJ, Wang W, Johnson DH, Aisner SC, Ettinger DS. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 2004;22(2):293-299.
50. Endo M, Nakagawa K, Ohde Y, et al. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors. Lung Cancer 2008;61(3):350-355.
51. Sung YM, Lee KS, Kim BT, Choi JY, Shim YM, Yi CA. 18F-FDG PET/CT of thymic epithelial tumors: usefulness for distinguishing and staging tumor subgroups. J Nucl Med 2006;47(10): 1628-1634.
52. Verley JM, Hollmann KH. Thymoma: a comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer 1985;55(5):1074-1086.